| TTM
|
2/28/2026
|
2/28/2025
|
2/29/2024
|
2/28/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
441 | 514 | 10,889 | 153 | 173 |
| Cost of Revenue
|
-381 | -381 | -218 | -- | -- |
|
Gross Profit
|
133 | 133 | 10,671 | -- | -- |
| Selling, General and Administrative Expenses
|
-6,332 | -6,405 | -9,228 | -9,988 | -20,429 |
|
Research and Development Expenses
|
-3,062 | -3,472 | -6,646 | -11,379 | -17,346 |
| Depreciation, Amortization and Depletion
|
-368 | -384 | -524 | -535 | -550 |
|
Operating Income/Expenses
|
-9,762 | -10,261 | -16,398 | -21,902 | -38,325 |
|
Total Operating Profit/Loss
|
-9,881 | -10,128 | -5,727 | -21,749 | -38,152 |
| Total Net Finance Income/Expense
|
204 | -59 | -128 | 599 | -148 |
| Net Investment Income
|
-2,560 | -2,112 | -742 | 63 | 316 |
| Irregular Income/Expenses
|
0 | 0 | -8,460 | 0 | 16,683 |
|
Non-Operating Income/Expenses, Total
|
-2,356 | -2,171 | -9,330 | 662 | 16,851 |
|
Pretax Income
|
-12,237 | -12,299 | -15,057 | -21,087 | -21,301 |
|
Net Income from Continuing Operations
|
-12,237 | -12,299 | -15,057 | -21,087 | -21,301 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-12,237 | -12,299 | -15,057 | -21,087 | -21,301 |
|
Net Income after Non-Controlling/Minority Interests
|
-12,237 | -12,299 | -15,057 | -21,087 | -21,301 |
|
Net Income Available to Common Stockholders
|
-12,237 | -12,299 | -15,057 | -21,087 | -21,301 |
|
Diluted Net Income Available to Common Stockholders
|
-12,237 | -12,299 | -15,057 | -21,087 | -21,301 |
| Basic EPS
|
-0.26 | -0.26 | -0.32 | -0.44 | -0.45 |
| Diluted EPS
|
-0.26 | -0.26 | -0.32 | -0.44 | -0.45 |
|
Basic Weighted Average Shares Outstanding
|
48,135.8020 | 47,960.9700 | 47,587.0380 | 47,522.4830 | 47,418.9490 |
|
Diluted Weighted Average Shares Outstanding
|
48,135.8020 | 47,960.9700 | 47,587.0380 | 47,522.4830 | 47,418.9490 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-12,500 | -12,282 | -14,973 | -21,482 | -21,186 |
|
EBITDA
|
-12,132 | -11,898 | -14,449 | -20,947 | -20,636 |
|
Normalized EBITDA
|
-10,075 | -10,315 | -4,637 | -18,708 | -27,233 |
|
Normalized Income
|
-10,180 | -10,716 | -5,245 | -18,848 | -27,898 |
|
Total Unusual Items
|
2,057 | 1,583 | 9,812 | 2,239 | -6,597 |
|
Total Unusual Items Excluding Goodwill
|
2,057 | 1,583 | 9,812 | 2,239 | -6,597 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
2/28/2023 - 11/20/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade